Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji Kumar, Philippe Moreau, Rakesh Popat et al.|The Lancet Oncology|2020Cited by 401
Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancerChunni Wang, Bo Han, Lin Wang et al.|The Prostate|2014Cited by 54
Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patientsHongxiang Du, Xiaoqing Yang|Cancer Cell International|2024Cited by 8
A CNN-BiLSTM algorithm for Weibo emotion classification with attention mechanismXinyue Feng, Xiaoqing Yang|Mathematical Models in Engineering|2024Cited by 4